September News Roundup: CBD, Delta-8, and the Evolving Hemp Landscape

As fall settles in, America continues to witness a dynamic and ever-changing sphere of CBD and hemp cannabinoid products and regulations. With recent developments hinting at both exciting opportunities and potential challenges, here’s your comprehensive monthly roundup of the most significant happenings in the world of cannabinoids.

Key Highlights

• 90 new state bills aimed at hemp regulation have been introduced.
• Cookies marks a historical deal with the University of Southern California.
• Cann’s innovative 2mg Grapefruit Rosemary tonic has become a fan favorite.

Major CBD and Delta-8 News

In an unprecedented move, the well-known cannabis brand Cookies has secured a multi-year sponsorship with the University of Southern California (USC) Trojans. This new partnership includes sponsorship of both the USC football team and their men’s and women’s basketball programs. Fans can look forward to experiencing “on-site tailgate experiences” at selected events, promising a blend of sports and cannabis culture entered on campus.

Legal Developments in CBD and Hemp

In a surprising twist, 2024 has seen an influx of 90 bills proposed in various states to regulate hemp. The Reason Foundation, a libertarian think tank, has introduced a proposition aiming to standardize the hemp sector across the U.S.

California’s CBD Market Turmoil

With rumors swirling about Governor Gavin Newsom’s impending emergency ban on all hemp products containing even trace amounts of THC, Californians are “panic buying” CBD and hemp products, fearing limited access in the near future.

Missouri’s Ongoing Controversy

Drama continues in Missouri as Governor Mike Parson’s campaign to ban intoxicating hemp products faces resistance. The state’s health department has temporarily allowed hemp sales to continue, much to the relief of businesses and consumers.

Texas at a Crossroads

The Texas Supreme Court’s decision regarding delta-8 sales is highly anticipated. With the state’s hemp market valued at a staggering $8.1 billion, and delta-8 accounting for $6.8 billion of that total, the outcome has far-reaching implications for the industry.

Federal Developments

In a landmark ruling, a U.S. Circuit Court determined on September 4 that THC-O, a potent hemp-derived cannabinoid, falls under the definition of hemp as per the 2018 Farm Bill. This decision stands in stark contrast to the DEA’s stance, suggesting legal complexities ahead for hemp products.

The U.S. Supreme Court will soon hear a case involving Douglas Horn, a truck driver who lost his job after failing a drug test linked to a supposedly THC-free CBD product. Meanwhile, the FDA has taken action against a North Carolina skincare brand, Root Bioscience Brands, for allegedly making unsubstantiated medical claims about their CBD products.

Introducing Cann’s 2 mg Tonics

While we cover the latest headlines, let’s highlight one of Leafly HQ’s exciting discoveries: Cann’s 2 mg Grapefruit Rosemary tonic. This delicious beverage, packaged in a sleek mini-can, offers a subtle and refreshing flavor profile, coupled with a mellow buzz that is perfect for winding down without overindulgence. It’s an exemplary product in the increasingly popular category of hemp-derived beverages.

Scientific Insights into CBD and Hemp

A recent study has sparked discussions within the cannabis community, revealing that CBD may actually enhance the psychoactive effects of cannabis rather than diminish them, contradicting long-held beliefs.

On another note, Foria’s CBD suppositories have demonstrated effectiveness, with nearly 80% of participants reporting significant relief from menstrual pain and discomfort.

In addition, Oregon State University has garnered a substantial grant of $5 million to continue its research into the potential applications of industrial hemp, paving the way for future innovations.

Industry Insights and Trends

As the market expands, a report from InsightAce Analytic predicts the CBD ingredient market could see revenues soar from $2.42 billion in 2023 to an impressive $6.77 billion by 2031. Such projections signal a burgeoning industry ripe with opportunity.

On the global stage, Canada has welcomed its first CBD lozenge by Aurora Cannabis and Vectura Fertin Pharma, exemplifying the steady growth in innovative CBD product offerings.

Additionally, the inaugural Pacific Hemp Beverage Summit is set to take place on October 11, 2024, in Bend, Oregon, promising an engaging platform for industry professionals to discuss advancements and trends.

Concluding Thoughts

The world of cannabinoids is undeniably dynamic, filled with new challenges and exciting developments. As we transition into a new month, we’ll continue to monitor these changes and report on the latest events shaping the future of CBD and hemp. Stay tuned for more updates!